Financials The Cooper Companies, Inc. Börse Stuttgart

Equities

CP60

US2166485019

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate Other stock markets 12:44:02 20/06/2024 pm IST			5-day change	1st Jan Change
85.4 ^EUR	+1.43%		-2.09%	-2.38%

06/06	Transcript : The Cooper Companies, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 01:30 PM
05/06	Transcript : The Cooper Companies, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 10:00 AM

Valuation

Fiscal Period: Oktober	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	14,426	15,646	20,556	13,491	15,439	18,251	-	-
Enterprise Value (EV) ¹	16,163	17,324	21,939	16,116	17,889	20,528	20,013	19,455
P/E ratio	31.2 x	66.3 x	7.05 x	35.2 x	52.7 x	42.1 x	30.2 x	25.8 x
Yield	0.02%	0.02%	0.01%	0.02%	0.02%	0.07%	0.04%	0.02%
Capitalization / Revenue	5.44 x	6.44 x	7.03 x	4.08 x	4.3 x	4.7 x	4.4 x	4.14 x
EV / Revenue	6.09 x	7.13 x	7.51 x	4.87 x	4.98 x	5.28 x	4.83 x	4.41 x
EV / EBITDA	18.2 x	24.1 x	23.6 x	17 x	14.7 x	17.8 x	15.9 x	14.3 x
EV / FCF	38.4 x	98.3 x	41.9 x	35.8 x	83.2 x	63.4 x	33.3 x	26.4 x
FCF Yield	2.61%	1.02%	2.39%	2.79%	1.2%	1.58%	3.01%	3.79%
Price to Book	4.01 x	4.14 x	2.99 x	1.89 x	2.04 x	2.28 x	2.15 x	2.02 x
Nbr of stocks (in thousands)	1,98,294	1,96,162	1,97,216	1,97,384	1,98,097	1,99,120	-	-
Reference price ²	72.75	79.76	104.2	68.35	77.94	91.66	91.66	91.66
Announcement Date	05/12/19	03/12/20	02/12/21	08/12/22	07/12/23	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Oktober	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	2,653	2,431	2,922	3,308	3,593	3,886	4,146	4,411
EBITDA ¹	886.2	719.9	930.9	948.9	1,218	1,150	1,258	1,364
EBIT ¹	732.2	570	767.7	782.3	850.8	945.6	1,033	1,128
Operating Margin	27.59%	23.45%	26.27%	23.65%	23.68%	24.33%	24.9%	25.57%
Earnings before Tax (EBT) ¹	477.4	266.5	491.5	475.3	412.9	558.3	709.8	849.4
Net income ¹	466.7	238.4	2,945	385.8	294.2	452.3	595.3	706.8
Net margin	17.59%	9.81%	100.76%	11.66%	8.19%	11.64%	14.36%	16.03%
EPS ²	2.332	1.202	14.79	1.940	1.478	2.177	3.038	3.556
Free Cash Flow ¹	421.1	176.2	524.2	450.4	215	324	601.5	737.1
FCF margin	15.87%	7.25%	17.94%	13.61%	5.98%	8.34%	14.51%	16.71%
FCF Conversion (EBITDA)	47.52%	24.48%	56.31%	47.47%	17.64%	28.17%	47.8%	54.05%
FCF Conversion (Net income)	90.23%	73.91%	17.8%	116.74%	73.08%	71.63%	101.04%	104.28%
Dividend per Share ²	0.0150	0.0150	0.0150	0.0150	0.0150	0.0600	0.0375	0.0150
Announcement Date	05/12/19	03/12/20	02/12/21	08/12/22	07/12/23	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: October	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3
Net sales ¹	787.2	829.8	843.4	848.1	858.5	877.4	930.2	927.1	931.6	942.6	997.5	1,011	991.5	1,010	1,063
EBITDA ¹	233.5	245.5	238.8	231.2	237.4	254	317.1	319.2	-	272.8	291.8	303.9	306.4	305.2	-
EBIT ¹	193.8	203.2	197.2	188.2	194.2	207.5	222.6	226.5	227.1	224.8	240.4	252.4	242.2	245.8	263.2
Operating Margin	24.62%	24.49%	23.38%	22.19%	22.62%	23.65%	23.93%	24.43%	24.38%	23.85%	24.1%	24.96%	24.43%	24.33%	24.77%
Earnings before Tax (EBT)	121.9	163.7	117.3	72.4	122.1	65.6	118.8	106.4	120	130	-	-	-	-	-
Net income ¹	95.3	126.6	98.4	65.6	84.6	39.8	85.3	84.5	81.2	88.9	135.5	142.4	156.1	158.7	185.4
Net margin	12.11%	15.26%	11.67%	7.73%	9.85%	4.54%	9.17%	9.11%	8.72%	9.43%	13.58%	14.08%	15.74%	15.7%	17.44%
EPS ²	0.4775	0.6375	0.4950	0.3300	0.4250	0.2000	0.4275	0.4250	0.4100	0.4400	0.6629	0.7043	0.7533	0.7533	0.8533
Dividend per Share	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	03/03/22	02/06/22	31/08/22	08/12/22	02/03/23	01/06/23	30/08/23	07/12/23	29/02/24	30/05/24	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: October	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	1,737	1,677	1,383	2,625	2,450	2,277	1,761	1,204
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.96 x	2.33 x	1.486 x	2.767 x	2.011 x	1.98 x	1.4 x	0.8827 x
Free Cash Flow ¹	421	176	524	450	215	324	601	737
ROE (net income / shareholders' equity)	13.5%	6.4%	12.2%	8.75%	8.66%	9.09%	9.43%	9.68%
ROA (Net income/ Total Assets)	7.54%	3.66%	8.06%	5.85%	5.51%	6.4%	6%	6.25%
Assets ¹	6,194	6,506	36,521	6,593	5,338	7,067	9,921	11,309
Book Value Per Share ²	18.10	19.30	34.80	36.10	38.10	40.10	42.60	45.50
Cash Flow per Share ²	3.570	2.450	3.710	3.480	3.050	3.960	4.930	5.500
Capex ¹	292	310	214	242	393	400	366	339
Capex / Sales	11.01%	12.77%	7.34%	7.31%	10.92%	10.3%	8.83%	7.68%
Announcement Date	05/12/19	03/12/20	02/12/21	08/12/22	07/12/23	-	-	-

¹USD in Million²USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for The Cooper Companies, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

91.66 USD

Average target price

108.2 USD

Spread / Average Target

+18.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
ALCON INC.	+19.68%	43.93B
AUTEK CHINA INC.	-25.42%	2.08B
WARBY PARKER INC.	+9.01%	1.83B
PEGAVISION CORPORATION	+20.55%	1.15B
SHANGHAI CONANT OPTICAL CO., LTD.	+78.47%	682M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-10.11%	651M
MINGYUE OPTICAL LENS CO.,LTD.	-45.68%	629M
MENICON CO., LTD.	-44.30%	626M
VISCO VISION INC.	+28.57%	542M

Glasses, Spectacles & Contact Lenses